Cholangiocarcinoma

• 

  Subject Areas on Research

  • A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. 
  • Adenosine triphosphate activates ion permeabilities in biliary epithelial cells. 
  • Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. 
  • Akt expression may predict favorable prognosis in cholangiocarcinoma. 
  • American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. 
  • Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings? 
  • Cholangiocarcinoma arising from intraductal papillary mucinous neoplasm of the bile duct. 
  • Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. 
  • Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. 
  • Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. 
  • Contrast-enhanced CT of intrahepatic and hilar cholangiocarcinoma: delay time for optimal imaging. 
  • Cystic duct patency in malignant obstructive jaundice. An ERCP-based study relevant to the role of laparoscopic cholecystojejunostomy. 
  • De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant. 
  • Endoscopic management of hilar cholangiocarcinoma. 
  • Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis. 
  • Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. 
  • Exome sequencing of liver fluke-associated cholangiocarcinoma. 
  • Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study. 
  • Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. 
  • Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? 
  • Gastric ulceration in a patient treated with SIR-spheres. 
  • Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes. 
  • Hedgehog signaling in cholangiocytes. 
  • Hepatic resection for primary hepatolithiasis: a single-center Western experience. 
  • High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy. 
  • Hilar cholangiocarcinoma. 
  • Intrahepatic cholangiocarcinoma: new insights in pathology. 
  • LI-RADS: a glimpse into the future. 
  • Laparoscopic staging for hepatobiliary carcinoma. 
  • Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. 
  • Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. 
  • Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. 
  • Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. 
  • Moving upstream in the war on WNTs. 
  • Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis. 
  • Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. 
  • New observation of sialuria prompts detection of liver tumor in previously reported patient. 
  • New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. 
  • Oncocytic differentiation in intrahepatic biliary cystadenocarcinoma. 
  • Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. 
  • Outcomes following resection of intrahepatic cholangiocarcinoma. 
  • PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma. 
  • Palliation of intractable cancer pain by MRI-guided cingulotomy. 
  • Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. 
  • Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases. 
  • Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy. 
  • Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers. 
  • Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation. 
  • Positron emission tomography in hepatobiliary and pancreatic malignancies: a review. 
  • Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. 
  • Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience. 
  • Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. 
  • Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients. 
  • Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. 
  • Radiation therapy in the treatment of cholangiocarcinoma. 
  • Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. 
  • Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. 
  • Radiological management of an inoperable cholangiocarcinoma arising from a choledochal cyst. 
  • Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma. 
  • Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models. 
  • Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. 
  • Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. 
  • The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. 
  • The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma. 
  • The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. 
  • The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia. 
  • Transplantation for cholangiocarcinoma. 
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? 
  • Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. 
  • Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. 
  • Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. 
  • Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. 
  • Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.